1. Home
  2. ALLR vs ICON Comparison

ALLR vs ICON Comparison

Compare ALLR & ICON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALLR
  • ICON
  • Stock Information
  • Founded
  • ALLR 2004
  • ICON 2023
  • Country
  • ALLR United States
  • ICON Greece
  • Employees
  • ALLR N/A
  • ICON N/A
  • Industry
  • ALLR Biotechnology: Pharmaceutical Preparations
  • ICON
  • Sector
  • ALLR Health Care
  • ICON
  • Exchange
  • ALLR Nasdaq
  • ICON Nasdaq
  • Market Cap
  • ALLR 4.0M
  • ICON 3.6M
  • IPO Year
  • ALLR N/A
  • ICON 2024
  • Fundamental
  • Price
  • ALLR $0.82
  • ICON $1.97
  • Analyst Decision
  • ALLR
  • ICON Strong Buy
  • Analyst Count
  • ALLR 0
  • ICON 1
  • Target Price
  • ALLR N/A
  • ICON $280.00
  • AVG Volume (30 Days)
  • ALLR 2.6M
  • ICON 850.7K
  • Earning Date
  • ALLR 05-13-2025
  • ICON 05-15-2025
  • Dividend Yield
  • ALLR N/A
  • ICON 0.19%
  • EPS Growth
  • ALLR N/A
  • ICON N/A
  • EPS
  • ALLR N/A
  • ICON 12.11
  • Revenue
  • ALLR N/A
  • ICON $4,810,000.00
  • Revenue This Year
  • ALLR N/A
  • ICON $32.17
  • Revenue Next Year
  • ALLR N/A
  • ICON $58.62
  • P/E Ratio
  • ALLR N/A
  • ICON $0.18
  • Revenue Growth
  • ALLR N/A
  • ICON 5.71
  • 52 Week Low
  • ALLR $0.68
  • ICON $1.60
  • 52 Week High
  • ALLR $174.00
  • ICON $154.00
  • Technical
  • Relative Strength Index (RSI)
  • ALLR 37.39
  • ICON N/A
  • Support Level
  • ALLR $0.91
  • ICON N/A
  • Resistance Level
  • ALLR $1.23
  • ICON N/A
  • Average True Range (ATR)
  • ALLR 0.14
  • ICON 0.00
  • MACD
  • ALLR -0.02
  • ICON 0.00
  • Stochastic Oscillator
  • ALLR 3.15
  • ICON 0.00

About ALLR Allarity Therapeutics Inc.

Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improves clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations.

About ICON Icon Energy Corp. Common stock

Icon Energy Corp is a Growth-oriented company that operates as a holding company for the purpose of acquiring, owning, chartering and operating dry bulk vessels through its subsidiaries. The company generates its revenues by chartering the Initial Vessels to regional and international dry bulk operators, commodity traders and end users.

Share on Social Networks: